Business Wire, July 19, 2010
DUBLIN — Research and Markets (http://www.researchandmarkets.com/research/8717d0/the_top_10_worlds)
has announced the addition of the “The
Top 10 World’s Leading Diagnostics Companies: Siemens” report to
their offering.
A New Thought-Provoking Report on Performance, Capabilities, Goals and
Strategies of the Major Competitors in the Worldwide Diagnostics Market
In a highly dynamic and fragmented in vitro diagnostics market, besieged
by intense competition, rapid pace of technological innovations and the
uncertainty regarding future government regulations, the ability to
anticipate new competitive product introductions and marketing
strategies is particularly important… and can spell the difference
between success and failure.
The TOP 10, a unique series of market intelligence studies and is
designed to provide the in vitro diagnostics industry executives, as
well as companies planning to diversify into the diagnostics field, with
strategically significant competitor information, analysis and insight,
critical to the development and implementation of effective marketing
and R&D programs. The study’s major objectives include: to establish a
comprehensive, factual, annually-updated and cost-effective information
base on performance, capabilities, goals and strategies of the worlds
leading in vitro diagnostics companies; to help current suppliers
realistically assess their financial, marketing and technological
capabilities vis-a-vis leading competitors; to assist potential market
entrants in evaluating prospective acquisitions and joint venture
candidates; and to complement organizations internal competitor
information gathering efforts by providing strategic analysis, data
interpretation and insight. The study provides an approximately 55-page
worldwide strategic overview of the in vitro diagnostics market,
including the 2006-2011 forecasts for major testing locations and
laboratory disciplines. Moreover, five-year worldwide sales projections
for the most dynamic market segments, such as molecular diagnostics,
infectious diseases, tumor markers, and personal testing were developed.
In addition, the study provides a concise review of major U.S
niche marketing
About the Author
